Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on August 10, 2005
J Am Soc Nephrol 16: 2920-2930, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004100895

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
ASN.2004100895v1
16/10/2920    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reynolds, J. L.
Right arrow Articles by Shanahan, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, J. L.
Right arrow Articles by Shanahan, C. M.

Basic Mineral Metabolism

Multifunctional Roles for Serum Protein Fetuin-A in Inhibition of Human Vascular Smooth Muscle Cell Calcification

Joanne L. Reynolds*, Jeremy N. Skepper{dagger}, Rosamund McNair*, Takeshi Kasama{ddagger}, Kunal Gupta*, Peter L. Weissberg*, Willi Jahnen-Dechent§ and Catherine M. Shanahan*

* Division of Cardiovascular Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom; {dagger} Multi-Imaging Centre, Department of Anatomy, Cambridge, United Kingdom; {ddagger} Department of Materials Science and Metallurgy, University of Cambridge, Cambridge, United Kingdom, and The Institute of Physical and Chemical Research, Hatoyama, Saitama, Japan; and § IZKF Biomat Aachen University Clinics, Aachen, Germany

Address correspondence to: Dr. Catherine M. Shanahan, Division of Cardiovascular Medicine, Level 6, ACCI, Box 110, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, UK. Phone: 44-1223-331504; Fax: 44-1223-331505; cs131{at}mole.bio.cam.ac.uk

Received for publication October 29, 2004. Accepted for publication July 2, 2005.

Vascular calcification predicts an increased risk for cardiovascular events/mortality in atherosclerosis, diabetes, and ESRD. Serum concentrations of {alpha}2-Heremens-Schmid glycoprotein, commonly referred to as fetuin-A, are reduced in ESRD, a condition associated with an elevated circulating calcium x phosphate product. Mice that lack fetuin-A exhibit extensive soft tissue calcification, which is accelerated on a mineral-rich diet, suggesting that fetuin-A acts to inhibit calcification systemically. Western blot and immunohistochemistry demonstrated that serum-derived fetuin-A co-localized with calcified human vascular smooth muscle cells (VSMC) in vitro and in calcified arteries in vivo. Fetuin-A inhibited in vitro VSMC calcification, induced by elevated concentrations of extracellular mineral ions, in a concentration-dependent manner. This was achieved in part through inhibition of apoptosis and caspase cleavage. Confocal microscopy and electron microscopy–immunogold demonstrated that fetuin-A was internalized by VSMC and concentrated in intracellular vesicles. Subsequently, fetuin-A was secreted via vesicle release from apoptotic and viable VSMC. Vesicles have previously been identified as the nidus for mineral nucleation. The presence of fetuin-A in vesicles abrogated their ability to nucleate basic calcium phosphate. In addition, fetuin-A enhanced phagocytosis of vesicles by VSMC. These observations provide evidence that the uptake of the serum protein fetuin-A by VSMC is a key event in the inhibition of vesicle-mediated VSMC calcification. Strategies aimed at maintaining normal circulating levels of fetuin-A may prove beneficial in patients with ESRD.




This article has been cited by other articles:


Home page
CirculationHome page
R. C. Shroff, R. McNair, N. Figg, J. N. Skepper, L. Schurgers, A. Gupta, M. Hiorns, A. E. Donald, J. Deanfield, L. Rees, et al.
Dialysis Accelerates Medial Vascular Calcification in Part by Triggering Smooth Muscle Cell Apoptosis
Circulation, October 21, 2008; 118(17): 1748 - 1757.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. C. Shroff, V. Shah, M. P. Hiorns, M. Schoppet, L. C. Hofbauer, G. Hawa, L. J. Schurgers, A. Singhal, I. Merryweather, P. Brogan, et al.
The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3263 - 3271.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Heiss, T. Eckert, A. Aretz, W. Richtering, W. van Dorp, C. Schafer, and W. Jahnen-Dechent
Hierarchical Role of Fetuin-A and Acidic Serum Proteins in the Formation and Stabilization of Calcium Phosphate Particles
J. Biol. Chem., May 23, 2008; 283(21): 14815 - 14825.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
D. A. Towler
Vascular Calcification: A Perspective On An Imminent Disease Epidemic
IBMS BoneKEy, February 1, 2008; 5(2): 41 - 58.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. M. Shanahan
Inflammation Ushers in Calcification: A Cycle of Damage and Protection?
Circulation, December 11, 2007; 116(24): 2782 - 2785.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z. Al-Aly, J.-S. Shao, C.-F. Lai, E. Huang, J. Cai, A. Behrmann, S.-L. Cheng, and D. A. Towler
Aortic Msx2-Wnt Calcification Cascade Is Regulated by TNF-{alpha} Dependent Signals in Diabetic Ldlr / Mice
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2589 - 2596.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Westenfeld, C. Schafer, R. Smeets, V. M. Brandenburg, J. Floege, M. Ketteler, and W. Jahnen-Dechent
Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1537 - 1546.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. P. Burke, F. D. Kolodgie, and R. Virmani
Fetuin-A, Valve Calcification, and Diabetes: What Do We Understand?
Circulation, May 15, 2007; 115(19): 2464 - 2467.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. A. Towler
Calciotropic Hormones and Arterial Physiology: "D"-lightful Insights
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 369 - 373.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. X. Chen, K. D. O'Neill, X. Chen, D. Duan, E. Wang, M. S. Sturek, J. M. Edwards, and S. M. Moe
Fetuin-A uptake in bovine vascular smooth muscle cells is calcium dependent and mediated by annexins
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F599 - F606.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. Lewin and K. Olgaard
Klotho, an important new factor for the activity of Ca2+ channels, connecting calcium homeostasis, ageing and uraemia
Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1770 - 1772.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-S. Shao, J. Cai, and D. A. Towler
Molecular Mechanisms of Vascular Calcification: Lessons Learned From The Aorta
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1423 - 1430.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Ketteler, G. Schlieper, and J. Floege
Calcification and Cardiovascular Health: New Insights Into an Old Phenomenon
Hypertension, June 1, 2006; 47(6): 1027 - 1034.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. M. Shanahan
Vascular calcification--a matter of damage limitation?
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1166 - 1169.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP